BeamMed Highlights the Future of Bone Health at Qualipalooza: RISE Quality Leadership Summit 2025

BeamMed will showcase its Mini Omni bone density scanner at Qualipalooza: RISE Quality Leadership Summit 2025. The Mini Omni offers a portable, radiation-free solution for early osteoporosis detection, helping providers expand access to screenings and improve patient outcomes in value-based care models.
Scottsdale, AZ - BeamMed, a leading innovator in bone health technology, is proud to announce its participation in Qualipalooza: RISE Quality Leadership Summit 2025 [https://www.beammed.com/events/qualipalooza-rise-quality-leadership-summit-2025/], taking place from June 29 to July 1, 2025, at the prestigious Fairmont Scottsdale Princess in Scottsdale, Arizona.

Qualipalooza [https://www.beammed.com/events/qualipalooza-rise-quality-leadership-summit-2025/] is the only conference that covers all four critical areas of quality improvement-Star Ratings, HEDIS Registered , CAHPS Registered , and state-specific Medicaid measures-in-depth, offering healthcare professionals a unique opportunity to sharpen their knowledge, connect with peers, and stay ahead of evolving industry trends. The event draws quality leaders, program directors, healthcare administrators, and policymakers who are committed to elevating standards of care in Medicare and Medicaid populations.

For BeamMed, this event provides a vital platform to engage with healthcare leaders who are shaping the future of value-based care and member health outcomes. With decades of experience in developing innovative solutions for bone health assessment, BeamMed is dedicated to supporting healthcare organizations in their efforts to improve patient care, meet quality benchmarks, and empower preventive care initiatives.

At Qualipalooza 2025, BeamMed will showcase its cutting-edge Mini Omni-a radiation-free, portable bone density scanner [https://www.beammed.com/sunlight-miniomni/] designed for early detection and monitoring of osteoporosis and bone health. The Mini Omni represents a game-changing solution for healthcare providers seeking a fast, accurate, and convenient way to assess bone density in various settings, from clinics and hospitals to community health programs and mobile screenings.

Unlike traditional bone density testing equipment [https://www.beammed.com/], which often requires bulky, expensive machinery and fixed installations, the Mini Omni is lightweight, compact, and easy to use. Its advanced ultrasound technology provides precise, non-invasive measurements of bone density, enabling early detection of osteoporosis and fracture risk without exposing patients to radiation. This makes the Mini Omni an ideal tool for healthcare providers working in value-based care models, where proactive health management and preventive screenings play a crucial role in achieving quality goals and improving patient outcomes.

BeamMed's presence at the RISE Quality Leadership Summit aligns with the event's mission to foster collaboration and innovation across the healthcare industry. By offering practical solutions that empower providers to deliver high-quality, patient-centered care, BeamMed is helping to bridge the gap between technology and improved health outcomes-particularly for populations at risk for osteoporosis and related conditions.

"Bone health is a critical but often overlooked aspect of preventive care, and we are excited to share the Mini Omni with healthcare professionals at Qualipalooza 2025," said a spokesperson for BeamMed. "Our mission is to make bone density assessment more accessible, affordable, and convenient, so that providers can detect problems earlier, intervene sooner, and ultimately help patients lead healthier, more active lives."

With thousands of BeamMed devices already in use across physician offices, clinics, HMOs, hospitals, research centers, and pharmacies worldwide, the Mini Omni builds on the company's proven track record of excellence in bone health technology. Its portable design empowers healthcare teams to expand access to screenings, whether during routine visits, community health events, or outreach programs for underserved populations.

Healthcare professionals attending Qualipalooza will have the opportunity to learn more about how the Mini Omni can help drive improvements in quality scores by supporting early intervention strategies and comprehensive care models. BeamMed invites all attendees to visit their booth to explore the Mini Omni in action, ask questions, and discover how this portable solution can fit into their quality improvement plans.

For more information about BeamMed and the Mini Omni bone density scanner, visit www.beammed.com, email info@beammed.com, or call 800-769-6808. BeamMed looks forward to connecting with healthcare leaders at Qualipalooza: RISE Quality Leadership Summit 2025 and continuing to make a positive impact on patient care worldwide.

About BeamMed:

BeamMed develops, manufactures, and markets advanced bone density assessment solutions [https://www.beammed.com/] that enable physicians to provide early detection, diagnosis, and monitoring of osteoporosis and bone age. With thousands of devices in use across the globe, BeamMed's technology is trusted by healthcare professionals dedicated to improving patient outcomes.

Media Contact
Company Name: BeamMed Inc.
Contact Person: Gilad Zamir
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=beammed-highlights-the-future-of-bone-health-at-qualipalooza-rise-quality-leadership-summit-2025]
Phone: 800-769-6808
Address:950 S. Pine Island Road
City: Plantation
State: Florida
Country: United States
Website: http://www.beammed.com

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.